Probiotics and intestinal diseases.
Rosenstiel
Philip
P
Institute for Clinical Molecular Biology, Christian-Albrechts-University, University Hospital Schleswig-Holstein, Kiel, Germany. p.rosenstiel@mucosa.de
Stange
Eduard F
EF
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D016481:Helicobacter Infections / Q000178:diet therapy*; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D007410:Intestinal Diseases / Q000178:diet therapy*; D019936:Probiotics / Q000627:therapeutic use*; D016896:Treatment Outcome